Arkolith/Insider Trading/VYNT/Form 4

Fremeau Robert Thomas Jr.

Chief Scientific OfficerVyant Bio, Inc. (VYNT) · full profile →Form 4 · filed Nov 17, 2021
Net Buying
Open-Market Buys
$2K
Open-Market Sells
$0
Net Open-Market Flow
$2K
Transactions
2
1 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 28, 2021Buy(P)1K$2.19$2K1K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Nov 1, 2021Grant(A)250K—$0250K

Transaction Codes

P
Open-market purchase
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-21-029137) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML